Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA's NDAC shuffle

This article was originally published in The Tan Sheet

Executive Summary

Late July meeting reduced to one day from three. NDAC will not meet July 27 or 28, as previously scheduled, but only on July 29 at the Bethesda Holiday Inn ("The Tan Sheet" March 2, p. 5). The topic for that day remains the same -- effectiveness testing for final formulations of antiseptic health care products under the Health Care Continuum Model, with the public hearing portion set for 1-2 p.m. The proposed topic for the next scheduled meeting on Sept. 11, pediatric labeling for combination drug products, now has been displaced by a discussion of FDA's OTC vaginal yeast infection draft guidance discussion. Pediatric labeling will be rescheduled...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS088669

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel